10X Genomics, Inc. (TXG)
63.79
-1.33
(-2.04%)
USD |
NASDAQ |
Aug 24, 16:00
63.79
0.00 (0.00%)
After-Hours: 20:00
10X Genomics Enterprise Value : 8.011B for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 8.011B |
| August 20, 2026 | 7.848B |
| August 19, 2026 | 7.629B |
| August 18, 2026 | 6.774B |
| August 17, 2026 | 7.082B |
| August 14, 2026 | 6.834B |
| August 13, 2026 | 7.103B |
| August 12, 2026 | 7.051B |
| August 11, 2026 | 7.146B |
| August 10, 2026 | 7.157B |
| August 07, 2026 | 6.305B |
| August 06, 2026 | 5.468B |
| August 05, 2026 | 5.710B |
| August 04, 2026 | 5.762B |
| August 03, 2026 | 5.651B |
| July 31, 2026 | 5.685B |
| July 30, 2026 | 5.967B |
| July 29, 2026 | 5.561B |
| July 28, 2026 | 5.657B |
| July 27, 2026 | 5.509B |
| July 24, 2026 | 5.555B |
| July 23, 2026 | 5.788B |
| July 22, 2026 | 5.657B |
| July 21, 2026 | 5.676B |
| July 20, 2026 | 5.158B |
| Date | Value |
|---|---|
| July 17, 2026 | 5.225B |
| July 16, 2026 | 5.322B |
| July 15, 2026 | 5.487B |
| July 14, 2026 | 5.492B |
| July 13, 2026 | 4.969B |
| July 10, 2026 | 5.094B |
| July 09, 2026 | 5.142B |
| July 08, 2026 | 4.408B |
| July 07, 2026 | 4.455B |
| July 06, 2026 | 4.738B |
| July 02, 2026 | 4.609B |
| July 01, 2026 | 4.614B |
| June 30, 2026 | 4.522B |
| June 29, 2026 | 4.333B |
| June 26, 2026 | 4.282B |
| June 25, 2026 | 4.150B |
| June 24, 2026 | 4.005B |
| June 23, 2026 | 3.652B |
| June 22, 2026 | 3.790B |
| June 18, 2026 | 4.025B |
| June 17, 2026 | 3.686B |
| June 16, 2026 | 3.637B |
| June 15, 2026 | 3.698B |
| June 12, 2026 | 3.262B |
| June 11, 2026 | 3.289B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Twist Bioscience Corp. | 9.051B |
| Alamar Biosciences, Inc. (California) | 2.177B |
| Personalis, Inc. | 1.780B |
| Adaptive Biotechnologies Corp. | 4.208B |
| Champions Oncology, Inc. | 68.73M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -17.93M |
| Revenue (Quarterly) | 151.04M |
| Total Expenses (Quarterly) | 168.97M |
| EPS Diluted (Quarterly) | -0.138 |
| Gross Profit Margin (Quarterly) | 74.36% |
| Profit Margin (Quarterly) | -11.87% |
| Earnings Yield | -0.92% |
| Normalized Earnings Yield | -0.9430 |